Vertex Pharmaceuticals Incorporated - Common Stock — Liquidità (NASDAQ:VRTX)

Financials

Flusso di cassa derivante dalle attività operative 3.25 B2.64 B4.13 B3.54 B-492.6 M3.63 B 4.24 B Flussi di cassa derivanti dalle attività di investimento 99.39 M-340.9 M-321.1 M-3.14 B-3.77 B-945.4 M -1.32 B Liquidità derivante dalle attività di finanziamento -505.28 M-1.48 B-67.7 M-562.2 M-1.49 B-2.26 B -2.12 B Liquidità libera 3.25 B2.64 B4.13 B3.54 B-492.6 M3.63 B 4.24 B

Vertex Pharmaceuticals Incorporated - Common Stock

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

VRTX

Financials

Vertex Pharmaceuticals Incorporated - Common Stock

Notizie

Vertex Pharmaceuticals Incorporated (VRTX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

JPMorgan says large-cap biotech is back as profits and pipelines fuel upside

Truist avvia copertura di Vertex con rating buy sui farmaci renali

BME: Discount Narrows, But A Strong Long-Term Hold Candidate Anyway

These Are The Upcoming Catalysts For Crispr Therapeutics Stock (NASDAQ:CRSP)

What Are Wall Street Analysts' Target Price for Vertex Pharmaceuticals Stock?

Vertex Pharmaceuticals Incorporated (VRTX) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Perché il titolo di Vertex Pharmaceuticals è in rialzo oggi?

VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 Earnings

Stock Market Soars On Tumbling Oil Prices, Strong Earnings: Weekly Review

BMO Capital mantiene il target di $17 su Vertex